STLN Market Cap History — Starling Oncology Capitalization Over Time

As of 7/30/2026 Starling Oncology has a market cap of 516.71 million. Investors often follow the STLN market cap history to compare the size of the company over time.

This page shows STLN market capitalization trends over time, with 2 market cap datapoints presented, dating back to 4/30/2026.

Quick links: Market Cap History Table  |  Market Cap History Chart  |  About Starling Oncology
STLN Market Cap History



Below is a table of the STLN market cap history going back to 4/30/2026:

Date STLN Market Cap
4/30/2026385.93M
7/30/2026516.71M

Also see: STLN Shares Outstanding History
and STLN YTD Return
STLN Historical Market Cap:
+135.92% CAGR
STLN Historical Market Cap: +135.92% CAGR

Mouse over chart for data details
4/30/20267/30/2026
The Oncology Institute, Inc. is a value-based oncology company. Co. manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the U.S.. Co.'s segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. Co., through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. We show 2 historical shares outstanding datapoints in our STLN shares outstanding history coverage, used to compute STLN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing STLN market cap history over the course of time is important for investors interested in comparing STLN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of STLN versus a peer is one thing; comparing STLN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like STLN can fluctuate over the course of history. With this page we aim to empower investors researching STLN by allowing them to research the STLN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree STLN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap
Starling Oncology (STLN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

STML Market Cap History
STOK Market Cap History
STRO Market Cap History
STSA Market Cap History
STSS Market Cap History
STTK Market Cap History
SUPN Market Cap History
SURF Market Cap History
SVA Market Cap History
SVRA Market Cap History
More Healthcare companies »
 

STLN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.